nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—ABCC1—Epirubicin—liver cancer	0.13	0.196	CbGbCtD
Indinavir—ABCC2—Sorafenib—liver cancer	0.0846	0.127	CbGbCtD
Indinavir—ABCC1—Doxorubicin—liver cancer	0.0693	0.104	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0565	0.0848	CbGbCtD
Indinavir—CYP3A7—Sorafenib—liver cancer	0.0565	0.0848	CbGbCtD
Indinavir—ABCC2—Doxorubicin—liver cancer	0.0513	0.077	CbGbCtD
Indinavir—ABCC2—bile canaliculus—liver cancer	0.0427	0.552	CbGeAlD
Indinavir—CYP3A5—Sorafenib—liver cancer	0.0424	0.0636	CbGbCtD
Indinavir—CYP2C19—Sorafenib—liver cancer	0.0342	0.0513	CbGbCtD
Indinavir—CYP2C9—Sorafenib—liver cancer	0.0284	0.0426	CbGbCtD
Indinavir—ABCB1—Sorafenib—liver cancer	0.0276	0.0414	CbGbCtD
Indinavir—CYP2D6—Sorafenib—liver cancer	0.026	0.039	CbGbCtD
Indinavir—ABCB1—Doxorubicin—liver cancer	0.0167	0.0251	CbGbCtD
Indinavir—CYP3A4—Sorafenib—liver cancer	0.0165	0.0248	CbGbCtD
Indinavir—CYP2D6—Doxorubicin—liver cancer	0.0158	0.0237	CbGbCtD
Indinavir—ABCC2—bile duct—liver cancer	0.0134	0.172	CbGeAlD
Indinavir—ABCC2—bile—liver cancer	0.0103	0.132	CbGeAlD
Indinavir—CYP3A4—Doxorubicin—liver cancer	0.01	0.015	CbGbCtD
Indinavir—CYP3A7—liver—liver cancer	0.00161	0.0207	CbGeAlD
Indinavir—CYP3A7-CYP3A51P—liver—liver cancer	0.00137	0.0176	CbGeAlD
Indinavir—SLCO1B1—liver—liver cancer	0.0011	0.0142	CbGeAlD
Indinavir—SLC22A1—liver—liver cancer	0.000931	0.012	CbGeAlD
Indinavir—SLCO1A2—liver—liver cancer	0.000896	0.0116	CbGeAlD
Indinavir—ABCC2—liver—liver cancer	0.000835	0.0108	CbGeAlD
Indinavir—ABCC1—liver—liver cancer	0.000736	0.0095	CbGeAlD
Indinavir—CYP2C19—liver—liver cancer	0.000718	0.00927	CbGeAlD
Indinavir—ABCB1—embryo—liver cancer	0.000649	0.00838	CbGeAlD
Indinavir—CYP3A5—liver—liver cancer	0.000565	0.0073	CbGeAlD
Indinavir—CYP2C9—liver—liver cancer	0.000556	0.00718	CbGeAlD
Indinavir—Myalgia—Sorafenib—liver cancer	0.000522	0.00333	CcSEcCtD
Indinavir—Herpes simplex—Doxorubicin—liver cancer	0.00052	0.00332	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000518	0.0033	CcSEcCtD
Indinavir—Nocturia—Doxorubicin—liver cancer	0.000517	0.0033	CcSEcCtD
Indinavir—Dermatitis contact—Epirubicin—liver cancer	0.000512	0.00327	CcSEcCtD
Indinavir—Dry mouth—Sorafenib—liver cancer	0.00051	0.00325	CcSEcCtD
Indinavir—Eructation—Epirubicin—liver cancer	0.000509	0.00325	CcSEcCtD
Indinavir—Creatinine increased—Doxorubicin—liver cancer	0.000503	0.00321	CcSEcCtD
Indinavir—Influenza like illness—Epirubicin—liver cancer	0.000503	0.00321	CcSEcCtD
Indinavir—Anaphylactic shock—Sorafenib—liver cancer	0.0005	0.00319	CcSEcCtD
Indinavir—Inflammation—Doxorubicin—liver cancer	0.000494	0.00315	CcSEcCtD
Indinavir—Shock—Sorafenib—liver cancer	0.000492	0.00314	CcSEcCtD
Indinavir—Nervous system disorder—Sorafenib—liver cancer	0.00049	0.00313	CcSEcCtD
Indinavir—Thrombocytopenia—Sorafenib—liver cancer	0.00049	0.00312	CcSEcCtD
Indinavir—Skin disorder—Sorafenib—liver cancer	0.000486	0.0031	CcSEcCtD
Indinavir—Musculoskeletal pain—Doxorubicin—liver cancer	0.000485	0.00309	CcSEcCtD
Indinavir—Anorexia—Sorafenib—liver cancer	0.000477	0.00304	CcSEcCtD
Indinavir—Dermatitis contact—Doxorubicin—liver cancer	0.000474	0.00302	CcSEcCtD
Indinavir—Eructation—Doxorubicin—liver cancer	0.000471	0.003	CcSEcCtD
Indinavir—Influenza like illness—Doxorubicin—liver cancer	0.000465	0.00297	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000456	0.00291	CcSEcCtD
Indinavir—Dyspnoea—Sorafenib—liver cancer	0.000446	0.00284	CcSEcCtD
Indinavir—Lymphadenopathy—Epirubicin—liver cancer	0.000441	0.00281	CcSEcCtD
Indinavir—Dyspepsia—Sorafenib—liver cancer	0.00044	0.00281	CcSEcCtD
Indinavir—Decreased appetite—Sorafenib—liver cancer	0.000435	0.00277	CcSEcCtD
Indinavir—Diabetes mellitus—Epirubicin—liver cancer	0.000432	0.00276	CcSEcCtD
Indinavir—Gastrointestinal disorder—Sorafenib—liver cancer	0.000432	0.00275	CcSEcCtD
Indinavir—Fatigue—Sorafenib—liver cancer	0.000431	0.00275	CcSEcCtD
Indinavir—Pain—Sorafenib—liver cancer	0.000428	0.00273	CcSEcCtD
Indinavir—Constipation—Sorafenib—liver cancer	0.000428	0.00273	CcSEcCtD
Indinavir—CYP3A4—liver—liver cancer	0.000424	0.00548	CbGeAlD
Indinavir—Hepatic failure—Epirubicin—liver cancer	0.000418	0.00267	CcSEcCtD
Indinavir—CYP2D6—liver—liver cancer	0.000417	0.00539	CbGeAlD
Indinavir—Eye pain—Epirubicin—liver cancer	0.000416	0.00266	CcSEcCtD
Indinavir—Gastrointestinal pain—Sorafenib—liver cancer	0.000409	0.00261	CcSEcCtD
Indinavir—Lymphadenopathy—Doxorubicin—liver cancer	0.000408	0.0026	CcSEcCtD
Indinavir—Renal failure acute—Epirubicin—liver cancer	0.000407	0.0026	CcSEcCtD
Indinavir—Increased appetite—Epirubicin—liver cancer	0.0004	0.00255	CcSEcCtD
Indinavir—Diabetes mellitus—Doxorubicin—liver cancer	0.0004	0.00255	CcSEcCtD
Indinavir—Urticaria—Sorafenib—liver cancer	0.000397	0.00253	CcSEcCtD
Indinavir—Body temperature increased—Sorafenib—liver cancer	0.000395	0.00252	CcSEcCtD
Indinavir—Abdominal pain—Sorafenib—liver cancer	0.000395	0.00252	CcSEcCtD
Indinavir—Renal impairment—Epirubicin—liver cancer	0.000395	0.00252	CcSEcCtD
Indinavir—Anaphylactoid reaction—Epirubicin—liver cancer	0.000388	0.00248	CcSEcCtD
Indinavir—Hepatic failure—Doxorubicin—liver cancer	0.000387	0.00247	CcSEcCtD
Indinavir—Eye pain—Doxorubicin—liver cancer	0.000385	0.00246	CcSEcCtD
Indinavir—Renal failure acute—Doxorubicin—liver cancer	0.000377	0.0024	CcSEcCtD
Indinavir—Pain in extremity—Epirubicin—liver cancer	0.000376	0.0024	CcSEcCtD
Indinavir—Increased appetite—Doxorubicin—liver cancer	0.00037	0.00236	CcSEcCtD
Indinavir—Hypersensitivity—Sorafenib—liver cancer	0.000368	0.00235	CcSEcCtD
Indinavir—Renal impairment—Doxorubicin—liver cancer	0.000366	0.00233	CcSEcCtD
Indinavir—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000359	0.00229	CcSEcCtD
Indinavir—Asthenia—Sorafenib—liver cancer	0.000359	0.00229	CcSEcCtD
Indinavir—Pruritus—Sorafenib—liver cancer	0.000354	0.00226	CcSEcCtD
Indinavir—Blood creatinine increased—Epirubicin—liver cancer	0.000352	0.00225	CcSEcCtD
Indinavir—Pain in extremity—Doxorubicin—liver cancer	0.000348	0.00222	CcSEcCtD
Indinavir—Dry skin—Epirubicin—liver cancer	0.000345	0.0022	CcSEcCtD
Indinavir—Diarrhoea—Sorafenib—liver cancer	0.000342	0.00218	CcSEcCtD
Indinavir—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000339	0.00216	CcSEcCtD
Indinavir—Gastritis—Epirubicin—liver cancer	0.000333	0.00212	CcSEcCtD
Indinavir—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000332	0.00212	CcSEcCtD
Indinavir—Muscular weakness—Epirubicin—liver cancer	0.000332	0.00212	CcSEcCtD
Indinavir—Dizziness—Sorafenib—liver cancer	0.000331	0.00211	CcSEcCtD
Indinavir—Abdominal distension—Epirubicin—liver cancer	0.000327	0.00209	CcSEcCtD
Indinavir—Blood creatinine increased—Doxorubicin—liver cancer	0.000326	0.00208	CcSEcCtD
Indinavir—Dry skin—Doxorubicin—liver cancer	0.000319	0.00203	CcSEcCtD
Indinavir—Pancreatitis—Epirubicin—liver cancer	0.000319	0.00203	CcSEcCtD
Indinavir—Vomiting—Sorafenib—liver cancer	0.000318	0.00203	CcSEcCtD
Indinavir—Angina pectoris—Epirubicin—liver cancer	0.000317	0.00202	CcSEcCtD
Indinavir—Rash—Sorafenib—liver cancer	0.000315	0.00201	CcSEcCtD
Indinavir—Dermatitis—Sorafenib—liver cancer	0.000315	0.00201	CcSEcCtD
Indinavir—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000313	0.002	CcSEcCtD
Indinavir—Headache—Sorafenib—liver cancer	0.000313	0.002	CcSEcCtD
Indinavir—Gastritis—Doxorubicin—liver cancer	0.000308	0.00196	CcSEcCtD
Indinavir—Muscular weakness—Doxorubicin—liver cancer	0.000307	0.00196	CcSEcCtD
Indinavir—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000307	0.00196	CcSEcCtD
Indinavir—Dysuria—Epirubicin—liver cancer	0.000304	0.00194	CcSEcCtD
Indinavir—Abdominal distension—Doxorubicin—liver cancer	0.000303	0.00193	CcSEcCtD
Indinavir—Upper respiratory tract infection—Epirubicin—liver cancer	0.000302	0.00193	CcSEcCtD
Indinavir—ABCB1—liver—liver cancer	0.0003	0.00388	CbGeAlD
Indinavir—Pollakiuria—Epirubicin—liver cancer	0.0003	0.00192	CcSEcCtD
Indinavir—Nausea—Sorafenib—liver cancer	0.000297	0.00189	CcSEcCtD
Indinavir—Weight increased—Epirubicin—liver cancer	0.000296	0.00189	CcSEcCtD
Indinavir—Pancreatitis—Doxorubicin—liver cancer	0.000295	0.00188	CcSEcCtD
Indinavir—Hyperglycaemia—Epirubicin—liver cancer	0.000293	0.00187	CcSEcCtD
Indinavir—Angina pectoris—Doxorubicin—liver cancer	0.000293	0.00187	CcSEcCtD
Indinavir—Pneumonia—Epirubicin—liver cancer	0.000291	0.00186	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000287	0.00183	CcSEcCtD
Indinavir—Renal failure—Epirubicin—liver cancer	0.000285	0.00182	CcSEcCtD
Indinavir—Neuropathy peripheral—Epirubicin—liver cancer	0.000284	0.00181	CcSEcCtD
Indinavir—Jaundice—Epirubicin—liver cancer	0.000282	0.0018	CcSEcCtD
Indinavir—Urinary tract infection—Epirubicin—liver cancer	0.000282	0.0018	CcSEcCtD
Indinavir—Dysuria—Doxorubicin—liver cancer	0.000281	0.00179	CcSEcCtD
Indinavir—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000279	0.00178	CcSEcCtD
Indinavir—Sweating—Epirubicin—liver cancer	0.000278	0.00177	CcSEcCtD
Indinavir—Pollakiuria—Doxorubicin—liver cancer	0.000278	0.00177	CcSEcCtD
Indinavir—Haematuria—Epirubicin—liver cancer	0.000276	0.00176	CcSEcCtD
Indinavir—Hepatobiliary disease—Epirubicin—liver cancer	0.000274	0.00175	CcSEcCtD
Indinavir—Weight increased—Doxorubicin—liver cancer	0.000274	0.00175	CcSEcCtD
Indinavir—Sinusitis—Epirubicin—liver cancer	0.000272	0.00173	CcSEcCtD
Indinavir—Hyperglycaemia—Doxorubicin—liver cancer	0.000271	0.00173	CcSEcCtD
Indinavir—Pneumonia—Doxorubicin—liver cancer	0.00027	0.00172	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000266	0.0017	CcSEcCtD
Indinavir—Renal failure—Doxorubicin—liver cancer	0.000264	0.00168	CcSEcCtD
Indinavir—Neuropathy peripheral—Doxorubicin—liver cancer	0.000263	0.00168	CcSEcCtD
Indinavir—Haemoglobin—Epirubicin—liver cancer	0.000261	0.00167	CcSEcCtD
Indinavir—Jaundice—Doxorubicin—liver cancer	0.000261	0.00167	CcSEcCtD
Indinavir—Urinary tract infection—Doxorubicin—liver cancer	0.000261	0.00166	CcSEcCtD
Indinavir—Haemorrhage—Epirubicin—liver cancer	0.00026	0.00166	CcSEcCtD
Indinavir—Hepatitis—Epirubicin—liver cancer	0.00026	0.00166	CcSEcCtD
Indinavir—Hypoaesthesia—Epirubicin—liver cancer	0.000259	0.00165	CcSEcCtD
Indinavir—Pharyngitis—Epirubicin—liver cancer	0.000258	0.00165	CcSEcCtD
Indinavir—Sweating—Doxorubicin—liver cancer	0.000257	0.00164	CcSEcCtD
Indinavir—Urinary tract disorder—Epirubicin—liver cancer	0.000257	0.00164	CcSEcCtD
Indinavir—Haematuria—Doxorubicin—liver cancer	0.000256	0.00163	CcSEcCtD
Indinavir—Connective tissue disorder—Epirubicin—liver cancer	0.000256	0.00163	CcSEcCtD
Indinavir—Urethral disorder—Epirubicin—liver cancer	0.000255	0.00163	CcSEcCtD
Indinavir—Hepatobiliary disease—Doxorubicin—liver cancer	0.000254	0.00162	CcSEcCtD
Indinavir—Sinusitis—Doxorubicin—liver cancer	0.000252	0.0016	CcSEcCtD
Indinavir—Erythema multiforme—Epirubicin—liver cancer	0.000246	0.00157	CcSEcCtD
Indinavir—Haemoglobin—Doxorubicin—liver cancer	0.000242	0.00154	CcSEcCtD
Indinavir—Flushing—Epirubicin—liver cancer	0.000241	0.00154	CcSEcCtD
Indinavir—Haemorrhage—Doxorubicin—liver cancer	0.000241	0.00154	CcSEcCtD
Indinavir—Hepatitis—Doxorubicin—liver cancer	0.000241	0.00154	CcSEcCtD
Indinavir—Hypoaesthesia—Doxorubicin—liver cancer	0.000239	0.00153	CcSEcCtD
Indinavir—Pharyngitis—Doxorubicin—liver cancer	0.000239	0.00152	CcSEcCtD
Indinavir—Urinary tract disorder—Doxorubicin—liver cancer	0.000238	0.00152	CcSEcCtD
Indinavir—Connective tissue disorder—Doxorubicin—liver cancer	0.000237	0.00151	CcSEcCtD
Indinavir—Urethral disorder—Doxorubicin—liver cancer	0.000236	0.00151	CcSEcCtD
Indinavir—Immune system disorder—Epirubicin—liver cancer	0.000235	0.0015	CcSEcCtD
Indinavir—Chills—Epirubicin—liver cancer	0.000233	0.00149	CcSEcCtD
Indinavir—Alopecia—Epirubicin—liver cancer	0.00023	0.00147	CcSEcCtD
Indinavir—Erythema multiforme—Doxorubicin—liver cancer	0.000228	0.00145	CcSEcCtD
Indinavir—Malnutrition—Epirubicin—liver cancer	0.000226	0.00144	CcSEcCtD
Indinavir—Flushing—Doxorubicin—liver cancer	0.000223	0.00142	CcSEcCtD
Indinavir—Flatulence—Epirubicin—liver cancer	0.000223	0.00142	CcSEcCtD
Indinavir—Tension—Epirubicin—liver cancer	0.000222	0.00142	CcSEcCtD
Indinavir—Dysgeusia—Epirubicin—liver cancer	0.000222	0.00141	CcSEcCtD
Indinavir—Nervousness—Epirubicin—liver cancer	0.00022	0.0014	CcSEcCtD
Indinavir—Back pain—Epirubicin—liver cancer	0.000219	0.0014	CcSEcCtD
Indinavir—Muscle spasms—Epirubicin—liver cancer	0.000218	0.00139	CcSEcCtD
Indinavir—Immune system disorder—Doxorubicin—liver cancer	0.000217	0.00139	CcSEcCtD
Indinavir—Chills—Doxorubicin—liver cancer	0.000216	0.00138	CcSEcCtD
Indinavir—Vision blurred—Epirubicin—liver cancer	0.000213	0.00136	CcSEcCtD
Indinavir—Alopecia—Doxorubicin—liver cancer	0.000213	0.00136	CcSEcCtD
Indinavir—Ill-defined disorder—Epirubicin—liver cancer	0.00021	0.00134	CcSEcCtD
Indinavir—Malnutrition—Doxorubicin—liver cancer	0.00021	0.00134	CcSEcCtD
Indinavir—Anaemia—Epirubicin—liver cancer	0.000209	0.00134	CcSEcCtD
Indinavir—Agitation—Epirubicin—liver cancer	0.000208	0.00133	CcSEcCtD
Indinavir—Flatulence—Doxorubicin—liver cancer	0.000206	0.00132	CcSEcCtD
Indinavir—Tension—Doxorubicin—liver cancer	0.000206	0.00131	CcSEcCtD
Indinavir—Dysgeusia—Doxorubicin—liver cancer	0.000205	0.00131	CcSEcCtD
Indinavir—Malaise—Epirubicin—liver cancer	0.000204	0.0013	CcSEcCtD
Indinavir—Nervousness—Doxorubicin—liver cancer	0.000203	0.0013	CcSEcCtD
Indinavir—Vertigo—Epirubicin—liver cancer	0.000203	0.0013	CcSEcCtD
Indinavir—Syncope—Epirubicin—liver cancer	0.000203	0.0013	CcSEcCtD
Indinavir—Back pain—Doxorubicin—liver cancer	0.000203	0.00129	CcSEcCtD
Indinavir—Muscle spasms—Doxorubicin—liver cancer	0.000201	0.00129	CcSEcCtD
Indinavir—Palpitations—Epirubicin—liver cancer	0.0002	0.00128	CcSEcCtD
Indinavir—Loss of consciousness—Epirubicin—liver cancer	0.000199	0.00127	CcSEcCtD
Indinavir—Cough—Epirubicin—liver cancer	0.000198	0.00126	CcSEcCtD
Indinavir—Vision blurred—Doxorubicin—liver cancer	0.000197	0.00126	CcSEcCtD
Indinavir—Ill-defined disorder—Doxorubicin—liver cancer	0.000194	0.00124	CcSEcCtD
Indinavir—Anaemia—Doxorubicin—liver cancer	0.000194	0.00124	CcSEcCtD
Indinavir—Arthralgia—Epirubicin—liver cancer	0.000193	0.00123	CcSEcCtD
Indinavir—Myalgia—Epirubicin—liver cancer	0.000193	0.00123	CcSEcCtD
Indinavir—Chest pain—Epirubicin—liver cancer	0.000193	0.00123	CcSEcCtD
Indinavir—Agitation—Doxorubicin—liver cancer	0.000193	0.00123	CcSEcCtD
Indinavir—Anxiety—Epirubicin—liver cancer	0.000192	0.00123	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000191	0.00122	CcSEcCtD
Indinavir—Discomfort—Epirubicin—liver cancer	0.00019	0.00122	CcSEcCtD
Indinavir—Malaise—Doxorubicin—liver cancer	0.000189	0.00121	CcSEcCtD
Indinavir—Dry mouth—Epirubicin—liver cancer	0.000189	0.0012	CcSEcCtD
Indinavir—Vertigo—Doxorubicin—liver cancer	0.000188	0.0012	CcSEcCtD
Indinavir—Syncope—Doxorubicin—liver cancer	0.000188	0.0012	CcSEcCtD
Indinavir—Palpitations—Doxorubicin—liver cancer	0.000185	0.00118	CcSEcCtD
Indinavir—Anaphylactic shock—Epirubicin—liver cancer	0.000185	0.00118	CcSEcCtD
Indinavir—Oedema—Epirubicin—liver cancer	0.000185	0.00118	CcSEcCtD
Indinavir—Loss of consciousness—Doxorubicin—liver cancer	0.000184	0.00117	CcSEcCtD
Indinavir—Cough—Doxorubicin—liver cancer	0.000183	0.00117	CcSEcCtD
Indinavir—Shock—Epirubicin—liver cancer	0.000182	0.00116	CcSEcCtD
Indinavir—Nervous system disorder—Epirubicin—liver cancer	0.000181	0.00116	CcSEcCtD
Indinavir—Thrombocytopenia—Epirubicin—liver cancer	0.000181	0.00115	CcSEcCtD
Indinavir—Skin disorder—Epirubicin—liver cancer	0.00018	0.00115	CcSEcCtD
Indinavir—Hyperhidrosis—Epirubicin—liver cancer	0.000179	0.00114	CcSEcCtD
Indinavir—Chest pain—Doxorubicin—liver cancer	0.000178	0.00114	CcSEcCtD
Indinavir—Myalgia—Doxorubicin—liver cancer	0.000178	0.00114	CcSEcCtD
Indinavir—Arthralgia—Doxorubicin—liver cancer	0.000178	0.00114	CcSEcCtD
Indinavir—Anxiety—Doxorubicin—liver cancer	0.000178	0.00113	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000177	0.00113	CcSEcCtD
Indinavir—Discomfort—Doxorubicin—liver cancer	0.000176	0.00112	CcSEcCtD
Indinavir—Anorexia—Epirubicin—liver cancer	0.000176	0.00112	CcSEcCtD
Indinavir—Dry mouth—Doxorubicin—liver cancer	0.000174	0.00111	CcSEcCtD
Indinavir—Oedema—Doxorubicin—liver cancer	0.000171	0.00109	CcSEcCtD
Indinavir—Anaphylactic shock—Doxorubicin—liver cancer	0.000171	0.00109	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000168	0.00107	CcSEcCtD
Indinavir—Shock—Doxorubicin—liver cancer	0.000168	0.00107	CcSEcCtD
Indinavir—Nervous system disorder—Doxorubicin—liver cancer	0.000168	0.00107	CcSEcCtD
Indinavir—Thrombocytopenia—Doxorubicin—liver cancer	0.000167	0.00107	CcSEcCtD
Indinavir—Insomnia—Epirubicin—liver cancer	0.000167	0.00107	CcSEcCtD
Indinavir—Skin disorder—Doxorubicin—liver cancer	0.000166	0.00106	CcSEcCtD
Indinavir—Paraesthesia—Epirubicin—liver cancer	0.000166	0.00106	CcSEcCtD
Indinavir—Hyperhidrosis—Doxorubicin—liver cancer	0.000165	0.00105	CcSEcCtD
Indinavir—Dyspnoea—Epirubicin—liver cancer	0.000165	0.00105	CcSEcCtD
Indinavir—Somnolence—Epirubicin—liver cancer	0.000164	0.00105	CcSEcCtD
Indinavir—Anorexia—Doxorubicin—liver cancer	0.000163	0.00104	CcSEcCtD
Indinavir—Dyspepsia—Epirubicin—liver cancer	0.000163	0.00104	CcSEcCtD
Indinavir—Decreased appetite—Epirubicin—liver cancer	0.000161	0.00102	CcSEcCtD
Indinavir—Gastrointestinal disorder—Epirubicin—liver cancer	0.00016	0.00102	CcSEcCtD
Indinavir—Fatigue—Epirubicin—liver cancer	0.000159	0.00102	CcSEcCtD
Indinavir—Pain—Epirubicin—liver cancer	0.000158	0.00101	CcSEcCtD
Indinavir—Constipation—Epirubicin—liver cancer	0.000158	0.00101	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000156	0.000994	CcSEcCtD
Indinavir—Insomnia—Doxorubicin—liver cancer	0.000155	0.000987	CcSEcCtD
Indinavir—Paraesthesia—Doxorubicin—liver cancer	0.000154	0.00098	CcSEcCtD
Indinavir—Dyspnoea—Doxorubicin—liver cancer	0.000152	0.000973	CcSEcCtD
Indinavir—Feeling abnormal—Epirubicin—liver cancer	0.000152	0.000972	CcSEcCtD
Indinavir—Somnolence—Doxorubicin—liver cancer	0.000152	0.00097	CcSEcCtD
Indinavir—Gastrointestinal pain—Epirubicin—liver cancer	0.000151	0.000964	CcSEcCtD
Indinavir—Dyspepsia—Doxorubicin—liver cancer	0.000151	0.00096	CcSEcCtD
Indinavir—Decreased appetite—Doxorubicin—liver cancer	0.000149	0.000948	CcSEcCtD
Indinavir—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000148	0.000942	CcSEcCtD
Indinavir—Fatigue—Doxorubicin—liver cancer	0.000147	0.00094	CcSEcCtD
Indinavir—Urticaria—Epirubicin—liver cancer	0.000147	0.000937	CcSEcCtD
Indinavir—Pain—Doxorubicin—liver cancer	0.000146	0.000933	CcSEcCtD
Indinavir—Constipation—Doxorubicin—liver cancer	0.000146	0.000933	CcSEcCtD
Indinavir—Abdominal pain—Epirubicin—liver cancer	0.000146	0.000932	CcSEcCtD
Indinavir—Body temperature increased—Epirubicin—liver cancer	0.000146	0.000932	CcSEcCtD
Indinavir—Feeling abnormal—Doxorubicin—liver cancer	0.000141	0.000899	CcSEcCtD
Indinavir—Gastrointestinal pain—Doxorubicin—liver cancer	0.00014	0.000892	CcSEcCtD
Indinavir—Hypersensitivity—Epirubicin—liver cancer	0.000136	0.000869	CcSEcCtD
Indinavir—Urticaria—Doxorubicin—liver cancer	0.000136	0.000867	CcSEcCtD
Indinavir—Abdominal pain—Doxorubicin—liver cancer	0.000135	0.000862	CcSEcCtD
Indinavir—Body temperature increased—Doxorubicin—liver cancer	0.000135	0.000862	CcSEcCtD
Indinavir—Asthenia—Epirubicin—liver cancer	0.000133	0.000846	CcSEcCtD
Indinavir—Pruritus—Epirubicin—liver cancer	0.000131	0.000834	CcSEcCtD
Indinavir—Diarrhoea—Epirubicin—liver cancer	0.000126	0.000807	CcSEcCtD
Indinavir—Hypersensitivity—Doxorubicin—liver cancer	0.000126	0.000804	CcSEcCtD
Indinavir—Asthenia—Doxorubicin—liver cancer	0.000123	0.000783	CcSEcCtD
Indinavir—Dizziness—Epirubicin—liver cancer	0.000122	0.00078	CcSEcCtD
Indinavir—Pruritus—Doxorubicin—liver cancer	0.000121	0.000772	CcSEcCtD
Indinavir—Vomiting—Epirubicin—liver cancer	0.000117	0.00075	CcSEcCtD
Indinavir—Diarrhoea—Doxorubicin—liver cancer	0.000117	0.000746	CcSEcCtD
Indinavir—Rash—Epirubicin—liver cancer	0.000117	0.000743	CcSEcCtD
Indinavir—Dermatitis—Epirubicin—liver cancer	0.000116	0.000743	CcSEcCtD
Indinavir—Headache—Epirubicin—liver cancer	0.000116	0.000739	CcSEcCtD
Indinavir—Dizziness—Doxorubicin—liver cancer	0.000113	0.000721	CcSEcCtD
Indinavir—Nausea—Epirubicin—liver cancer	0.00011	0.0007	CcSEcCtD
Indinavir—Vomiting—Doxorubicin—liver cancer	0.000109	0.000694	CcSEcCtD
Indinavir—Rash—Doxorubicin—liver cancer	0.000108	0.000688	CcSEcCtD
Indinavir—Dermatitis—Doxorubicin—liver cancer	0.000108	0.000687	CcSEcCtD
Indinavir—Headache—Doxorubicin—liver cancer	0.000107	0.000683	CcSEcCtD
Indinavir—Nausea—Doxorubicin—liver cancer	0.000102	0.000648	CcSEcCtD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	1.74e-05	0.000175	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTA4—liver cancer	1.73e-05	0.000174	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	1.73e-05	0.000174	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PPARA—liver cancer	1.72e-05	0.000173	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NAT2—liver cancer	1.72e-05	0.000173	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTA2—liver cancer	1.7e-05	0.000171	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—GSTM1—liver cancer	1.7e-05	0.000171	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—GSTP1—liver cancer	1.7e-05	0.000171	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.7e-05	0.000171	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CYP1A1—liver cancer	1.7e-05	0.000171	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ALDOB—liver cancer	1.69e-05	0.00017	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.69e-05	0.00017	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTA2—liver cancer	1.69e-05	0.00017	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—HMOX1—liver cancer	1.68e-05	0.000168	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ALDOB—liver cancer	1.65e-05	0.000166	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTA1—liver cancer	1.64e-05	0.000165	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTA1—liver cancer	1.63e-05	0.000164	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PSMA4—liver cancer	1.63e-05	0.000164	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PSMD10—liver cancer	1.63e-05	0.000164	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NAT2—liver cancer	1.62e-05	0.000163	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CRABP1—liver cancer	1.62e-05	0.000162	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CYP1A1—liver cancer	1.61e-05	0.000162	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NAT2—liver cancer	1.61e-05	0.000162	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	1.59e-05	0.00016	CbGpPWpGaD
Indinavir—ABCC1—Disease—APC—liver cancer	1.59e-05	0.00016	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GOT2—liver cancer	1.58e-05	0.000159	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—MTHFR—liver cancer	1.58e-05	0.000159	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GSTP1—liver cancer	1.58e-05	0.000159	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CRABP1—liver cancer	1.58e-05	0.000159	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	1.58e-05	0.000158	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—GSTM1—liver cancer	1.56e-05	0.000157	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—HMOX1—liver cancer	1.56e-05	0.000157	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ALDOB—liver cancer	1.56e-05	0.000157	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PPARA—liver cancer	1.55e-05	0.000156	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.55e-05	0.000156	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.55e-05	0.000156	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ALDOB—liver cancer	1.54e-05	0.000155	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.54e-05	0.000154	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—MTHFR—liver cancer	1.5e-05	0.000151	CbGpPWpGaD
Indinavir—ABCC1—Disease—BRAF—liver cancer	1.49e-05	0.00015	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP2E1—liver cancer	1.49e-05	0.00015	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CRABP1—liver cancer	1.49e-05	0.000149	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CYP1A1—liver cancer	1.48e-05	0.000149	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CG—liver cancer	1.48e-05	0.000148	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PPARA—liver cancer	1.47e-05	0.000148	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CRABP1—liver cancer	1.47e-05	0.000148	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.45e-05	0.000146	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GSTM1—liver cancer	1.45e-05	0.000146	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PPARG—liver cancer	1.43e-05	0.000143	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—HPGDS—liver cancer	1.41e-05	0.000142	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.4e-05	0.000141	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CD—liver cancer	1.4e-05	0.00014	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.39e-05	0.00014	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYCS—liver cancer	1.39e-05	0.00014	CbGpPWpGaD
Indinavir—ABCC1—Disease—SERPINE1—liver cancer	1.38e-05	0.000139	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—MTHFR—liver cancer	1.38e-05	0.000139	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—HPGDS—liver cancer	1.38e-05	0.000139	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CYP1A1—liver cancer	1.38e-05	0.000138	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GGT1—liver cancer	1.37e-05	0.000137	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GOT1—liver cancer	1.37e-05	0.000137	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PPARA—liver cancer	1.35e-05	0.000136	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CG—liver cancer	1.33e-05	0.000134	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.33e-05	0.000133	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.32e-05	0.000133	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CPT1B—liver cancer	1.32e-05	0.000132	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GLUL—liver cancer	1.32e-05	0.000132	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—HPGDS—liver cancer	1.3e-05	0.000131	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CD—liver cancer	1.3e-05	0.000131	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.3e-05	0.00013	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—HPGDS—liver cancer	1.29e-05	0.000129	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—MTHFR—liver cancer	1.28e-05	0.000129	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PPARG—liver cancer	1.28e-05	0.000129	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—ALB—liver cancer	1.28e-05	0.000129	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.28e-05	0.000129	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.28e-05	0.000129	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NR1H4—liver cancer	1.27e-05	0.000128	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CG—liver cancer	1.26e-05	0.000127	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.26e-05	0.000127	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PPARA—liver cancer	1.26e-05	0.000127	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PSMA4—liver cancer	1.26e-05	0.000127	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PSMD10—liver cancer	1.26e-05	0.000127	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTA3—liver cancer	1.25e-05	0.000126	CbGpPWpGaD
Indinavir—ABCC1—Disease—RAF1—liver cancer	1.25e-05	0.000125	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PSMD10—liver cancer	1.23e-05	0.000124	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PSMA4—liver cancer	1.23e-05	0.000124	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTP1—liver cancer	1.23e-05	0.000123	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GOT2—liver cancer	1.22e-05	0.000123	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PPARG—liver cancer	1.22e-05	0.000123	CbGpPWpGaD
Indinavir—ABCC1—Disease—MTOR—liver cancer	1.22e-05	0.000122	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CB—liver cancer	1.22e-05	0.000122	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—HMOX1—liver cancer	1.21e-05	0.000122	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GOT2—liver cancer	1.2e-05	0.00012	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.17e-05	0.000118	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CD—liver cancer	1.17e-05	0.000117	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.17e-05	0.000117	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CG—liver cancer	1.16e-05	0.000117	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PSMA4—liver cancer	1.16e-05	0.000116	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PSMD10—liver cancer	1.16e-05	0.000116	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—ALB—liver cancer	1.15e-05	0.000116	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP2E1—liver cancer	1.15e-05	0.000116	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.15e-05	0.000116	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PSMA4—liver cancer	1.15e-05	0.000115	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PSMD10—liver cancer	1.15e-05	0.000115	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTA4—liver cancer	1.14e-05	0.000115	CbGpPWpGaD
Indinavir—ABCC1—Disease—CDKN1B—liver cancer	1.14e-05	0.000115	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CB—liver cancer	1.13e-05	0.000114	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTM1—liver cancer	1.13e-05	0.000113	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GOT2—liver cancer	1.13e-05	0.000113	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP2E1—liver cancer	1.12e-05	0.000113	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PPARG—liver cancer	1.12e-05	0.000112	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GOT2—liver cancer	1.12e-05	0.000112	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.11e-05	0.000112	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTA2—liver cancer	1.11e-05	0.000112	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CD—liver cancer	1.11e-05	0.000112	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ALB—liver cancer	1.1e-05	0.00011	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CG—liver cancer	1.08e-05	0.000108	CbGpPWpGaD
Indinavir—ABCC1—Disease—CTNNB1—liver cancer	1.08e-05	0.000108	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYCS—liver cancer	1.08e-05	0.000108	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTA1—liver cancer	1.07e-05	0.000108	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP1A1—liver cancer	1.07e-05	0.000108	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NAT2—liver cancer	1.06e-05	0.000107	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.06e-05	0.000107	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP2E1—liver cancer	1.06e-05	0.000106	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GOT1—liver cancer	1.06e-05	0.000106	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GGT1—liver cancer	1.06e-05	0.000106	CbGpPWpGaD
Indinavir—ABCC1—Disease—CDKN1A—liver cancer	1.05e-05	0.000106	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYCS—liver cancer	1.05e-05	0.000106	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP2E1—liver cancer	1.05e-05	0.000106	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PPARG—liver cancer	1.04e-05	0.000105	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GOT1—liver cancer	1.03e-05	0.000104	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GGT1—liver cancer	1.03e-05	0.000104	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CD—liver cancer	1.02e-05	0.000102	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALDOB—liver cancer	1.02e-05	0.000102	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CB—liver cancer	1.02e-05	0.000102	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.02e-05	0.000102	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ALB—liver cancer	1.01e-05	0.000101	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—MTHFR—liver cancer	9.97e-06	0.0001	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYCS—liver cancer	9.91e-06	9.96e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYCS—liver cancer	9.82e-06	9.87e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PPARA—liver cancer	9.79e-06	9.84e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GOT1—liver cancer	9.72e-06	9.77e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GGT1—liver cancer	9.72e-06	9.77e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CRABP1—liver cancer	9.72e-06	9.77e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CB—liver cancer	9.68e-06	9.73e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GOT1—liver cancer	9.64e-06	9.69e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GGT1—liver cancer	9.64e-06	9.69e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTP1—liver cancer	9.49e-06	9.54e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CD—liver cancer	9.48e-06	9.53e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—STAT3—liver cancer	9.4e-06	9.45e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—HMOX1—liver cancer	9.36e-06	9.41e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ALB—liver cancer	9.36e-06	9.41e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTP1—liver cancer	9.27e-06	9.32e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—HMOX1—liver cancer	9.14e-06	9.19e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CB—liver cancer	8.88e-06	8.93e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—MYC—liver cancer	8.73e-06	8.78e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTP1—liver cancer	8.73e-06	8.78e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTM1—liver cancer	8.73e-06	8.77e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—TGFB1—liver cancer	8.71e-06	8.76e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTP1—liver cancer	8.66e-06	8.7e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—HMOX1—liver cancer	8.61e-06	8.66e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—HMOX1—liver cancer	8.54e-06	8.58e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTM1—liver cancer	8.52e-06	8.56e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HPGDS—liver cancer	8.49e-06	8.54e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CG—liver cancer	8.38e-06	8.42e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP1A1—liver cancer	8.27e-06	8.31e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CB—liver cancer	8.27e-06	8.31e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PPARG—liver cancer	8.09e-06	8.13e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP1A1—liver cancer	8.07e-06	8.12e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—KRAS—liver cancer	8.07e-06	8.11e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTM1—liver cancer	8.03e-06	8.07e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTM1—liver cancer	7.96e-06	8e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—MTHFR—liver cancer	7.71e-06	7.75e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP1A1—liver cancer	7.61e-06	7.65e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PSMA4—liver cancer	7.57e-06	7.61e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PSMD10—liver cancer	7.57e-06	7.61e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PPARA—liver cancer	7.57e-06	7.6e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP1A1—liver cancer	7.54e-06	7.58e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—MTHFR—liver cancer	7.53e-06	7.57e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CA—liver cancer	7.41e-06	7.45e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PPARA—liver cancer	7.38e-06	7.42e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CD—liver cancer	7.37e-06	7.41e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GOT2—liver cancer	7.36e-06	7.4e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ALB—liver cancer	7.27e-06	7.31e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—MTHFR—liver cancer	7.09e-06	7.13e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—MTHFR—liver cancer	7.03e-06	7.07e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PPARA—liver cancer	6.96e-06	6.99e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP2E1—liver cancer	6.92e-06	6.96e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CA—liver cancer	6.9e-06	6.94e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PPARA—liver cancer	6.9e-06	6.93e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—HRAS—liver cancer	6.86e-06	6.89e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.8e-06	6.83e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—IL6—liver cancer	6.56e-06	6.6e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CG—liver cancer	6.48e-06	6.51e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYCS—liver cancer	6.48e-06	6.51e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CB—liver cancer	6.42e-06	6.45e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GOT1—liver cancer	6.36e-06	6.39e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GGT1—liver cancer	6.36e-06	6.39e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CG—liver cancer	6.32e-06	6.36e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PPARG—liver cancer	6.25e-06	6.29e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CA—liver cancer	6.21e-06	6.24e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.2e-06	6.23e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PPARG—liver cancer	6.1e-06	6.13e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—AKT1—liver cancer	6.06e-06	6.09e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CG—liver cancer	5.96e-06	5.99e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CG—liver cancer	5.91e-06	5.94e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CA—liver cancer	5.9e-06	5.93e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PPARG—liver cancer	5.75e-06	5.78e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTP1—liver cancer	5.71e-06	5.74e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PPARG—liver cancer	5.7e-06	5.73e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CD—liver cancer	5.7e-06	5.73e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—AKT1—liver cancer	5.64e-06	5.67e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HMOX1—liver cancer	5.63e-06	5.66e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ALB—liver cancer	5.62e-06	5.65e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CD—liver cancer	5.56e-06	5.59e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ALB—liver cancer	5.49e-06	5.52e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CA—liver cancer	5.42e-06	5.44e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTM1—liver cancer	5.25e-06	5.27e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CD—liver cancer	5.24e-06	5.27e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CD—liver cancer	5.19e-06	5.22e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ALB—liver cancer	5.17e-06	5.2e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ALB—liver cancer	5.13e-06	5.15e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—AKT1—liver cancer	5.07e-06	5.1e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CA—liver cancer	5.04e-06	5.07e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP1A1—liver cancer	4.97e-06	5e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CB—liver cancer	4.96e-06	4.99e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CB—liver cancer	4.85e-06	4.87e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AKT1—liver cancer	4.82e-06	4.85e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—MTHFR—liver cancer	4.64e-06	4.66e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CB—liver cancer	4.57e-06	4.59e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PPARA—liver cancer	4.55e-06	4.57e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CB—liver cancer	4.53e-06	4.55e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AKT1—liver cancer	4.42e-06	4.45e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AKT1—liver cancer	4.12e-06	4.14e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CA—liver cancer	3.91e-06	3.93e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CG—liver cancer	3.9e-06	3.92e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PPARG—liver cancer	3.76e-06	3.78e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CD—liver cancer	3.42e-06	3.44e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALB—liver cancer	3.38e-06	3.4e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AKT1—liver cancer	3.2e-06	3.21e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CA—liver cancer	3.03e-06	3.04e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CB—liver cancer	2.99e-06	3e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CA—liver cancer	2.95e-06	2.97e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CA—liver cancer	2.78e-06	2.8e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CA—liver cancer	2.76e-06	2.77e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AKT1—liver cancer	2.47e-06	2.49e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AKT1—liver cancer	2.41e-06	2.43e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AKT1—liver cancer	2.27e-06	2.29e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AKT1—liver cancer	2.25e-06	2.27e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CA—liver cancer	1.82e-06	1.83e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKT1—liver cancer	1.49e-06	1.49e-05	CbGpPWpGaD
